Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Formica Capital in connection with its acquisition of the Rototec Group, the biggest supplier of geoenergy solutions in Europe
Mandate

Vinge advises Formica Capital in connection with its acquisition of the Rototec Group, the biggest supplier of geoenergy solutions in Europe

November 25, 2021 M&A Banking and Finance

Vinge has advised Formica Capital in connection with its acquisition of all shares in the Rototec Group. Rototec is a market leader in the field of geoenergy solutions for medium and large sized properties and handles Europe’s largest fleet of drilling equipment for geoenergy issues in Finland, Sweden and Norway.

Vinge’s team mainly consisted of Magnus Pauli (M&A), Johanna Hamrefält (Project Manager, M&A), Alexander Lindeberg (IP), Adam Loewenstein (M&A), Malin Olsson (HR), Hanna Marberg (M&A) as well as Fabian Ekeblad (Banking & Finance) and Elin Samara (Banking & Finance). Krogerus Attorneys acted as local counsel in Finland with Advokatfirmaet Thommessen AS acting as local counsel in Norway.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025